Karianne G. Schuurman
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2023
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation.
Journal: Molecular oncology
Published: May 02, 2023
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity.
Journal: EMBO molecular medicine
Published: March 21, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.
Journal: medRxiv : the preprint server for health sciences
Published: March 03, 2023
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.
Journal: Cell reports. Medicine
Published: February 24, 2023
PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription.
Journal: Nucleic acids research
Published: January 23, 2023
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence.
Journal: Cancer discovery
Published: May 03, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.
Journal: Nature communications
Published: September 30, 2020
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Journal: International journal of cancer
Published: April 08, 2019
Last Updated: 09/26/2026